Tuberculosis (TB) remains one of the most serious infectious diseases, especially when it becomes drug-resistant. Early and accurate diagnosis is extremely important to start the right treatment on time. Jeevan Rekha Hospital now introduces Advanced CBNAAT (Cartridge Based Nucleic Acid Amplification Test) technology in Uttar Dinajpur, offering rapid and reliable TB detection within a very short time.
CBNAAT is a modern molecular diagnostic test designed to detect Tuberculosis bacteria along with Rifampicin resistance, one of the major indicators of drug-resistant TB. Unlike traditional testing methods that may take several days or weeks, this advanced system provides highly accurate reports in less than 90 minutes.
The test is effective for both Pulmonary and Extra-Pulmonary TB cases, helping doctors make faster and better treatment decisions. With molecular drug susceptibility testing (DST), patients can receive early diagnosis and appropriate medication without unnecessary delays.
At Jeevan Rekha Hospital, experienced professionals and advanced laboratory infrastructure ensure quality testing and dependable reports. The hospital aims to strengthen the fight against drug-resistant TB by bringing world-class diagnostic services closer to the people of Raiganj and Uttar Dinajpur.
Key Benefits of Advanced CBNAAT
- Fast and accurate TB detection
- Detects Rifampicin resistance
- Reports available within 90 minutes
- Molecular Drug Susceptibility Testing (DST)
- Pulmonary & Extra-Pulmonary testing available
- Helps in early treatment planning
Early diagnosis saves lives. If you or your loved ones are experiencing symptoms related to TB, visit Jeevan Rekha Hospital for Advanced CBNAAT testing and expert medical guidance.
